Export 48 results:
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Wahlgren WY, Dunevall E, North RA, Paz, iv A, Scalise M, Bisignano P, Bengtsson-Palme J, Goyal P, Claesson E, Caing-Carlsson R, Andersson R, Beis K, Nilsson UJ, Farewell A, Pochini L, Indiveri C, Grabe M, Dobson RCJ, Abramson J, Ramaswamy S et al..  2018.  Substrate-bound outward-open structure of a Na-coupled sialic acid symporter reveals a new Na site.. Nat Commun. 9(1):1753. DOI:10.1038/s41467-018-04045-7.
North RA, Wahlgren WY, Remus DM, Scalise M, Kessans SA, Dunevall E, Claesson E, da Costa TPSoares, Perugini MA, Ramaswamy S, Allison JR, Indiveri C, Friemann R, Dobson RCJ.  2018.  The Sodium Sialic Acid Symporter From Has Altered Substrate Specificity.. Front Chem. 6:233. DOI:10.3389/fchem.2018.00233.
Bozzola T, Scalise M, Larsson CU, Newton-Vesty MC, Rovegno C, Mitra A, Cramer J, Wahlgren WYuan, Santhakumari PRadhakrish, Johnsson RE, Schwardt O, Ernst B, Friemann R, Dobson RCJ, Indiveri C, Schelin J, Nilsson UJ, Ellervik U.  2022.  Sialic Acid Derivatives Inhibit SiaT Transporters and Delay Bacterial Growth.. ACS Chem Biol. 17(7):1890-1900. DOI:10.1021/acschembio.2c00321.
Mlcochova P, Kemp SA, Dhar MShanker, Papa G, Meng B, Ferreira IATM, Datir R, Collier DA, Albecka A, Singh S, Pandey R, Brown J, Zhou J, Goonawardane N, Mishra S, Whittaker C, Mellan T, Marwal R, Datta M, Sengupta S et al..  2021.  SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.. Nature. 599(7883):114-119. DOI:10.1038/s41586-021-03944-y.
Mlcochova P, Kemp SA, Dhar MShanker, Papa G, Meng B, Ferreira IATM, Datir R, Collier DA, Albecka A, Singh S, Pandey R, Brown J, Zhou J, Goonawardane N, Mishra S, Whittaker C, Mellan T, Marwal R, Datta M, Sengupta S et al..  2021.  SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.. Nature. 599(7883):114-119. DOI:10.1038/s41586-021-03944-y.
I
Ludwig TE, Andrews PW, Barbaric I, Benvenisty N, Bhattacharyya A, Crook JM, Daheron LM, Draper JS, Healy LE, Huch M, Inamdar MS, Jensen KB, Kurtz A, Lancaster MA, Liberali P, Lutolf MP, Mummery CL, Pera MF, Sato Y, Shimasaki N et al..  2023.  ISSCR standards for the use of human stem cells in basic research.. Stem Cell Reports. 18(9):1744-1752. DOI:10.1016/j.stemcr.2023.08.003.
Ikonomou L, Cuende N, Forte M, Grilley BJ, Levine AD, Munsie M, Rasko JEJ, Turner L, Bidkhori HR, Ciccocioppo R, Grignon F, Srivastava A, Weiss DJ, Zettler P, Levine BL.  2023.  International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.. Cytotherapy. 25(9):920-929. DOI:10.1016/j.jcyt.2023.03.002.
Ikonomou L, Cuende N, Forte M, Grilley BJ, Levine AD, Munsie M, Rasko JEJ, Turner L, Bidkhori HR, Ciccocioppo R, Grignon F, Srivastava A, Weiss DJ, Zettler P, Levine BL.  2023.  International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.. Cytotherapy. 25(9):920-929. DOI:10.1016/j.jcyt.2023.03.002.
Jebanesan DZechariah, Illangeswaran RStephen St, Rajamani BM, Vidhyadharan RThalayattu, Das S, Bijukumar NK, Balakrishnan B, Mathews V, Velayudhan SR, Balasubramanian P.  2024.  Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia.. Ann Hematol. 103(6):1919-1929. DOI:10.1007/s00277-024-05742-8.
Asokan MS, Joan RFlorina, Babji S, Dayma G, Nadukkandy P, Subrahmanyam V, Pandey A, Malagi G, Arya P, Mahajan V, Bhavikatti J, Pawar K, Thorat A, Shah P, Goud RB, Roy B, Rajukutty S, Immanuel S, Agarwal D, Saha S et al..  2024.  Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study.. Lancet Reg Health Southeast Asia. 22:100361. DOI:10.1016/j.lansea.2024.100361.
Asokan MS, Joan RFlorina, Babji S, Dayma G, Nadukkandy P, Subrahmanyam V, Pandey A, Malagi G, Arya P, Mahajan V, Bhavikatti J, Pawar K, Thorat A, Shah P, Goud RB, Roy B, Rajukutty S, Immanuel S, Agarwal D, Saha S et al..  2024.  Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study.. Lancet Reg Health Southeast Asia. 22:100361. DOI:10.1016/j.lansea.2024.100361.
Benjamin ESathya Bam, Vinod E, Illangeswaran RStephen St, Rajamani BM, Vidhyadharan RThalayattu, Bagchi A, Maity A, Mohan A, Parasuraman G, Amirtham SManickam, Abraham A, Velayudhan SR, Balasubramanian P.  2024.  Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs.. Cell Signal. 116:111067. DOI:10.1016/j.cellsig.2024.111067.
Anstey NJ, Kapgal V, Tiwari S, Watson TC, Toft AKH, Dando OR, Inkpen FH, Baxter PS, Kozić Z, Jackson AD, He X, Nawaz MSarfaraz, Kayenaat A, Bhattacharya A, Wyllie DJA, Chattarji S, Wood ER, Hardt O, Kind PC.  2022.  Imbalance of flight-freeze responses and their cellular correlates in the Nlgn3 rat model of autism.. Mol Autism. 13(1):34. DOI:10.1186/s13229-022-00511-8.

Pages